Pfizer Settles Foreign Bribery Charges With Prosecution Deferred
This article was originally published in The Tan Sheet
Executive Summary
Pfizer settles with DoJ and SEC to resolve charges its subsidiaries bribed foreign government officials; a subsidiary enters a deferred prosecution agreement with DoJ. In a separate case, Pfizer’s Wyeth subsidiary agrees to pay $18.9 million in disgorgement of net profits and prejudgment interest to SEC.